Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biosimilar strategic implementation at a large health system.
Kar I, Kronz M, Kolychev E, Silverman P, Mendiratta P, Tomlinson BKN, Prunty J, Copley M, Patel S, Caudill S, Farah L, Wesolowski B, Crissinger T, Kendig C, Szymczak E, Duraj L, Dumot J, Acheson E, Lyamkin S, King M, Mocilnikar A, Cunningham K, Paulic N, Botzki U, Lerman R, Strosaker R, Osborne S, Glotzbecker B. Kar I, et al. Among authors: glotzbecker b. Am J Health Syst Pharm. 2022 Feb 8;79(4):268-275. doi: 10.1093/ajhp/zxab410. Am J Health Syst Pharm. 2022. PMID: 34752608
Efficacy and cost-benefit of filgrastim administered after early assessment bone marrow biopsy during induction therapy for acute myeloid leukemia.
Wang J, de Lima M, Cooper BW, Boughan K, Metheny L, Otegbeye F, Caimi PF, Gallogly M, Malek E, Cao S, Fu P, Glotzbecker B, Schiltz NK, Tomlinson BK. Wang J, et al. Among authors: glotzbecker b. Leuk Lymphoma. 2021 Jun;62(6):1450-1457. doi: 10.1080/10428194.2020.1864350. Epub 2021 Jan 18. Leuk Lymphoma. 2021. PMID: 33461376
Evaluating the adverse effects of melphalan formulations.
Xiang E, Ni J, Glotzbecker B, Laubach J, Soiffer R, McDonnell AM. Xiang E, et al. Among authors: glotzbecker b. J Oncol Pharm Pract. 2019 Oct;25(7):1631-1637. doi: 10.1177/1078155218804042. Epub 2018 Oct 18. J Oncol Pharm Pract. 2019. PMID: 30336728
Donor chimerism early after reduced-intensity conditioning hematopoietic stem cell transplantation predicts relapse and survival.
Koreth J, Kim HT, Nikiforow S, Milford EL, Armand P, Cutler C, Glotzbecker B, Ho VT, Antin JH, Soiffer RJ, Ritz J, Alyea EP 3rd. Koreth J, et al. Among authors: glotzbecker b. Biol Blood Marrow Transplant. 2014 Oct;20(10):1516-21. doi: 10.1016/j.bbmt.2014.05.025. Epub 2014 Jun 4. Biol Blood Marrow Transplant. 2014. PMID: 24907627 Free PMC article.
42 results